An empirical study on the impact of executive compensation incentives on the performance of Chinese pharmaceutical firms

Huihui Zhang, Boyi Xu, Su Wang, Yuwen Chen

Open source

DOI: 10.3389/fpubh.2026.1962847
Published: 2026-10-23
Container: Frontiers in Public Health
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fpubh.2026.1962847,
  title = {An empirical study on the impact of executive compensation incentives on the performance of Chinese pharmaceutical firms},
  author = {Huihui Zhang and Boyi Xu and Su Wang and Yuwen Chen},
  year = {2026},
  journal = {Frontiers in Public Health},
  doi = {10.3389/fpubh.2026.1962847},
  url = {https://doi.org/10.3389/fpubh.2026.1962847}
}

RIS

TY  - JOUR
TI  - An empirical study on the impact of executive compensation incentives on the performance of Chinese pharmaceutical firms
AU  - Huihui Zhang
AU  - Boyi Xu
AU  - Su Wang
AU  - Yuwen Chen
PY  - 2026
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1962847
UR  - https://doi.org/10.3389/fpubh.2026.1962847
ER  -

APA

Zhang, H., Xu, B., Wang, S., & Chen, Y. (2026). An empirical study on the impact of executive compensation incentives on the performance of Chinese pharmaceutical firms. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1962847

Source records

crossref · retrieved 2026-11-10T07:44:25.325Z